Post-activation Potentiation and Sprinting Performance (PAP-SP)

December 3, 2024 updated by: Chariklia K. Deli, University of Thessaly

Investigation of Post-activation Potentiation Phenomenon οn Sprinting Performance Following Power Pre-conditioning Exercise

Scientific data regarding the post-activation potentiation (PAP) phenomenon on sprinting performance is scarce, especially regarding the effect of performing pre-conditioning power exercises on subsequent sprinting performance. Additionally, there is no data regarding the rate of fatigue onset when power pre-conditioning exercise before sprints are performed repeatedly at the same training session. This research will provide important information to coaches and athletes for the design of an optimum training program for the maximization of the athletes' performance and the avoidance of injuries.

Study Overview

Detailed Description

Sprinting ability is an imperative quality for many sports, especially for sprint and power athletes. Regular sprint training improves acceleration, maximal speed and power. Thus, sprint training consists one of the basic elements of the athletes' training program.

One method used by coaches to improve performance is the implementation of a pre-conditioning exercise aiming to post-activation potentiation (PAP). Post-activation potentiation phenomenon refers to the increase in performance following a maximal or near maximal muscle contraction (e.g. a pre-conditioning exercise). However, the effectiveness of such an approach is under debate, such that improvement, but also no improvement, or even deterioration of the performance following pre-conditioning exercises has been reported. The improvement of performance following a pre-conditioning exercise seems to depend on the relationship between muscle twitch potentiation and fatigue following the pre-conditioning exercise. When muscle twitch potentiation is greater than muscle fatigue, then the PAP mechanism will be activated and performance will be improved. Contrary, under similar muscle twitch potentiation and fatigue, performance will not change, and when muscle twitch potentiation is lower than fatigue, muscle performance will decrease. PAP phenomenon has been studied mainly regarding its effectiveness to improve jumping performance, while its effectiveness on improving sprinting performance has not been adequately studied. However, information regarding the effectiveness of the implementation of pre-conditioning exercises aiming to improve sprinting performance, is important for the design of an optimum training program for the maximization of the athletes' performance and the avoidance of injuries.

The aim of this study is to investigate a) the effectiveness of the implementation of a pre-conditioning exercise to activate the PAP mechanism and improve performance of a following sprint, and b) to investigate whether PAP is maintained in repeated efforts during the same training session.

The study will be implemented in a randomized, cross over, repeated measures design, at three cycles.

According to a preliminary power analysis (a probability error of 0.05, and a statistical power of 80%), a sample size of 8 - 10 participants was considered appropriate in order to detect statistically meaningful differences between groups. Considering a possible drop-out, 15 participants will be recruited. Procedures will be in accordance with the 1964 Declaration of Helsinki, as revised in 2013.

Before the experimental procedures, all participants will sign an informed consent form after they will be informed about all the benefits and risks of the study, and they will also fill in a medical history questionnaire. Participants will then perform baseline measurements at the Laboratory of Biochemistry, Physiology and Nutrition of Exercise (SmArT Lab), Department of Physical Education and Sport Science, University of Thessaly: anthropometric characteristics (body height, body mass, body mass index) via a stadiometer-scale (Stadiometer 208; Seca, Birmingham, UK), body composition (percent of body fat, lean body mass, fat mass, bone density) via dual emission X-ray absorptiometry (DXA, GE-Healthcare, Lunar DPX NT, Belgium), isokinetic strength (isometric, concentric and eccentric torque of the knee extensors and knee flexors of both limbs) on an isokinetic dynamometer (Cybex, HUMAC NORM 360, Ronkonkoma, NY). The individual optimum rest period between the pre-conditioning exercise and the subsequent 30-m sprint will be estimated, in order each participant to perfrom each 30-m sprint under an optimal condition. The rest periods of 3, 6, and 9 minutes will be tested for each participant and the rest period that leads to the best sprinting performance will be applied during the experimental training protocols.

Participants will then perform 6 x 30-m sprints under three different conditions in a random order: a) control trial (sprint training without pre-conditioning exercise), b) sprint training with pre-conditioning exercise (2 x 4 squat jumps with 0% of 1RM at squat), and c) sprint training with pre-conditioning exercise (2 x 4 squat jumps with 20% of 1RM at squat). The randomization of the trials will be made via a random integer set generator (Random.org) available online.

Prior to, and following each 30-m sprint, assessment of muscle soreness in the knee flexors and knee extensors, countermovement jump height, and blood lactate concentration, will be performed during each training session. The exact above procedures will be repeated by the participants during the remaining two experimental trials. Between trials, a wash-out period of 7 days will be applied.

Study Type

Interventional

Enrollment (Actual)

15

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Thessaly
      • Trikala, Thessaly, Greece, 42100
        • Department of Physical Education and Sport Science, University of Thessaly

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Age: 18 - 30 years old
  • Srinters or athletes that comprise sprint training in their training programs
  • Absense of musculoskeletal injuries (≥ 6 months)
  • Abstence from use of ergogenic supplements or other drugs (≥ 1 month)
  • Abstence from participation at exercise with eccentric component (≥ 3 days)
  • Abstence from alcohol and energy drings consumption before each experimental trial

Exclusion Criteria:

  • Age: Older than 18 - 30 years
  • Musculoskeletal injuries (≤ 6 months)
  • Use of ergogenic supplements or other drugs (≤ 1 month)
  • Participation at exercise with eccentric component (≤ 3 days)
  • Alcohol and energy drings consumption before the experimental trials

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Screening
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: PAP exercise with 0% body mass
The participants will perform 6 x 30m sprints. A pre-conditioning exercise (2 sets x 4 countermovement jumps with 0% body mass).
The participants will perform 6 x 30m sprints. Before each sprint they will perform 2 x 4 countermovement jumps with 0% body mass.
Other Names:
  • post-activation potentiation training
  • sprint training
Experimental: PAP exercise with 20% body mass
The participants will perform 6 x 30m sprints. A pre-conditioning exercise (2 sets x 4 countermovement jumps with 20% body mass).
Description: The participants will perform 6 x 30m sprints. Before each sprint they will perform 2 x 4 countermovement jumps with 0% body mass
Other Names:
  • post-activation potentiation training
  • sprint training
Placebo Comparator: No PAP exercise
The participants will perform only 6 x 30m sprints. No pre-conditioning exercise will be performed.
No PAP exercise will be performed. The participants will perform only 6 x 30m sprints.
Other Names:
  • post-activation potentiation training
  • sprint training

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in 30 m sprint performance
Time Frame: Pre, 9, 18, 27, 36, and 45 minutes during the sprint training session.
30-m sprint performance will be assessed via photocells.
Pre, 9, 18, 27, 36, and 45 minutes during the sprint training session.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in muscle soreness in the knee flexors and extensors of both limbs
Time Frame: Pre, 9, 18, 27, 36, and 45 minutes during the sprint training session.
Muscle soreness will be assessed immediately post each 30-m sprint. Muscle soreness will be assessed via palpation of the muscle belly and the distal regions following 3 squats, and the subjective pain will be recorded on a 10-point scale (1 = no pain, 10 = extreme pain)
Pre, 9, 18, 27, 36, and 45 minutes during the sprint training session.
Changes in countermovement jump performance
Time Frame: Pre, 12, 21, 30, 39, and 58 minutes during the sprint training session.
Countermovement jump performance will be assessed 3 minutes post each 30-m sprint via an optical measurement system
Pre, 12, 21, 30, 39, and 58 minutes during the sprint training session.
Changes in lactate
Time Frame: Pre, 13, 22, 31, 40, and 49 minutes during the sprint training session.
Lactate will be measured 4 minutes following each 30-m sprint via a lactate portable analyser.
Pre, 13, 22, 31, 40, and 49 minutes during the sprint training session.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Chariklia K Deli, Associate Professor, University of Thessaly

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2024

Primary Completion (Actual)

November 15, 2024

Study Completion (Actual)

November 15, 2024

Study Registration Dates

First Submitted

September 17, 2024

First Submitted That Met QC Criteria

September 28, 2024

First Posted (Actual)

October 1, 2024

Study Record Updates

Last Update Posted (Estimated)

December 4, 2024

Last Update Submitted That Met QC Criteria

December 3, 2024

Last Verified

December 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sprint Performance

Clinical Trials on PAP exercise with 0% body mass

Subscribe